Dubai and Woburn, MA USA, — Courtagen Life Sciences Inc. announced today they have signed an exclusive strategic distribution agreement with the Alliance Global Group (AGBL) to help clinicians in emerging markets diagnose and manage a number of genetically based disorders. Courtagen’s test menu currently offers clinical tests for mitochondrial disorders (mtSEEK™ and nucSEEK™) and […]
Marcy l’Etoile (France) and Lexington, MA (U.S.) –— bioMérieux and Quanterix announced today that they have entered into a strategic agreement that gives bioMérieux worldwide exclusive rights to Quanterix’s Simoa technology in clinical laboratories and for industrial applications. Under the agreement, Quanterix will deliver a new instrument and consumables based on its Simoa technology. bioMérieux […]
Munich, Germany, – Definiens AG, the leader in image analysis for Digital Pathology, today announced that Dr. Gerald Möller, has joined the company’s supervisory board as an independent member and has been appointed chairman. Following the recent financing round, Dr. Möller will guide the expansion of Definiens’ current business and the development and commercialization of […]
MADISON, Wis.–Promega Corporation celebrates the opening of a new facility for its China operations. The new site for Shanghai Promega Biological Products, Ltd. both replaces an existing molecular biology reagent production site and it provides additional research, development and cGMP manufacturing capabilities for molecular diagnostics products for the Chinese market. Since its purchase in June […]
Trovagene, Inc., Announces Third Quarter and Year to Date Earnings, Provides Milestone Update COMPANY CONTINUES TO DEVELOP PROGRAMS IN CANCER AND INFECTIOUS DISEASE DETECTION IN URINE SAN DIEGO, CA – November 14, 2012 – PRNewswire — Trovagene, Inc. (NASDAQ: TROV), a developer of transrenal molecular diagnostics, today reported its financial results for the three and […]
SUNNYVALE, Calif.–Arrayit Corporation (OTCQB:ARYC) (“ARYC”) is pleased to announce that Arrayit Diagnostics, Inc. (“AD”) has filed an S-1 registration statement with the Securities and Exchange Commission today. Upon the effective date of the registration statement, AD will be an independently traded public company and will distribute one share of AD for approximately every 3.34 shares […]
Waltham, Mass. and Shanghai, China – PerkinElmer, Inc. (NYSE: PKI), a global leader focused on the health and safety of people and the environment, announced today that it has completed the acquisition of Shanghai Haoyuan Biotech Co., Ltd., a China-based infectious disease diagnostics company. The acquisition extends PerkinElmer’s capabilities into nucleic acid blood screening and […]
Kuala Lumpur, Malaysia, Sengenics, Asia’s 1st Genetic Diagnostics Company, today announced that it has entered into an exclusive agreement with The Sequenom Center for Molecular Medicine (Sequenom CMM), to launch and promote its MaterniT21 PLUS non-invasive prenatal testing service in Malaysia and Singapore. Sengenics will work with medical practitioners in the region to prescribe MaterniT21 […]
NEW YORK — Enzo Biochem Inc. (NYSE:ENZ) announced today that its Enzo Clinical Labs has introduced a new diagnostic test that assists in risk assessment and early detection of lung cancer. It is being made available to physicians in the New York metropolitan market as well as New Jersey and Eastern Pennsylvania, where Enzo is […]
CHICAGO & DUBLIN, Calif. & JENA, Germany — Medical technology provider Carl Zeiss Meditec announced today the introduction of a new family of ZEISS OCT (Optical Coherence Tomography) products at the 2012 AAO-APAO Joint Meeting in Chicago. The new CIRRUS OCT family is comprised of two new CIRRUS™ HD-OCT products, models 5000 and 500, and […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
